Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Transcatheter aortic valve implantation with the ACURATE neo valve : indications, procedural aspects and clinical outcomes. / Collaborators.

I: EuroIntervention, Bind 15, Nr. 18, 2020, s. e1571-e1579.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Collaborators 2020, 'Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes', EuroIntervention, bind 15, nr. 18, s. e1571-e1579. https://doi.org/10.4244/EIJ-D-19-00908

APA

Collaborators (2020). Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes. EuroIntervention, 15(18), e1571-e1579. https://doi.org/10.4244/EIJ-D-19-00908

Vancouver

Collaborators. Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes. EuroIntervention. 2020;15(18):e1571-e1579. https://doi.org/10.4244/EIJ-D-19-00908

Author

Collaborators. / Transcatheter aortic valve implantation with the ACURATE neo valve : indications, procedural aspects and clinical outcomes. I: EuroIntervention. 2020 ; Bind 15, Nr. 18. s. e1571-e1579.

Bibtex

@article{dfbe64e2b05241908259fc0c2eab59e2,
title = "Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes",
abstract = "The ACURATE neo aortic valve system is a self-expanding transcatheter device that was granted CE mark in 2014 and has since been widely adopted in the treatment of patients with severe aortic stenosis. The ACURATE neo can be used in a wide clinical spectrum, but there are some specific indications and anatomies where this device is particularly suitable. Recently, it was shown that, with appropriate patient screening, size selection, and optimised positioning, results can be improved substantially. This review provides an overview of existing data and compiles a standardised manual of best practice for the implantation of this device based on both evidence and individual experience.",
keywords = "Aortic Valve/diagnostic imaging, Aortic Valve Stenosis/diagnostic imaging, Heart Valve Prosthesis, Humans, Prosthesis Design, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome",
author = "Won-Keun Kim and Christian Hengstenberg and Michael Hilker and Ulrich Sch{\"a}fer and Rudolph, {Tanja K} and Stefan Toggweiler and Andreas R{\"u}ck and Lars S{\o}ndergaard and Lenard Conradi and Christian Hamm and Thomas Walther and Helge M{\"o}llmann and Collaborators",
year = "2020",
doi = "10.4244/EIJ-D-19-00908",
language = "English",
volume = "15",
pages = "e1571--e1579",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "Europa Digital & Publishing",
number = "18",

}

RIS

TY - JOUR

T1 - Transcatheter aortic valve implantation with the ACURATE neo valve

T2 - indications, procedural aspects and clinical outcomes

AU - Kim, Won-Keun

AU - Hengstenberg, Christian

AU - Hilker, Michael

AU - Schäfer, Ulrich

AU - Rudolph, Tanja K

AU - Toggweiler, Stefan

AU - Rück, Andreas

AU - Søndergaard, Lars

AU - Conradi, Lenard

AU - Hamm, Christian

AU - Walther, Thomas

AU - Möllmann, Helge

AU - Collaborators

PY - 2020

Y1 - 2020

N2 - The ACURATE neo aortic valve system is a self-expanding transcatheter device that was granted CE mark in 2014 and has since been widely adopted in the treatment of patients with severe aortic stenosis. The ACURATE neo can be used in a wide clinical spectrum, but there are some specific indications and anatomies where this device is particularly suitable. Recently, it was shown that, with appropriate patient screening, size selection, and optimised positioning, results can be improved substantially. This review provides an overview of existing data and compiles a standardised manual of best practice for the implantation of this device based on both evidence and individual experience.

AB - The ACURATE neo aortic valve system is a self-expanding transcatheter device that was granted CE mark in 2014 and has since been widely adopted in the treatment of patients with severe aortic stenosis. The ACURATE neo can be used in a wide clinical spectrum, but there are some specific indications and anatomies where this device is particularly suitable. Recently, it was shown that, with appropriate patient screening, size selection, and optimised positioning, results can be improved substantially. This review provides an overview of existing data and compiles a standardised manual of best practice for the implantation of this device based on both evidence and individual experience.

KW - Aortic Valve/diagnostic imaging

KW - Aortic Valve Stenosis/diagnostic imaging

KW - Heart Valve Prosthesis

KW - Humans

KW - Prosthesis Design

KW - Transcatheter Aortic Valve Replacement/adverse effects

KW - Treatment Outcome

U2 - 10.4244/EIJ-D-19-00908

DO - 10.4244/EIJ-D-19-00908

M3 - Review

C2 - 31911402

VL - 15

SP - e1571-e1579

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 18

ER -

ID: 269534609